Canopy Rivers’ (TSXV:RIV) portfolio company, Radicle Medical Marijuana, received a production and sales licence from Health Canada to supply and sell finished cannabis products for both the medical and adult-use market in Canada.
Canopy Rivers works collaboratively with Canopy Growth (TSX:WEED, NYSE:CGC) to identify strategic parties seeking financial and/or operating support.
Radicle operates a 140,000-square-foot indoor facility and is focused on small-batch cultivation of unique genetic strains using proprietary and sustainable growth methods.
In August 2018, Radicle was one of the original 26 licensed cannabis producers selected by the Ontario Cannabis Store for recreational online sales. Radicle recently launched Gage Cannabis, a new premium brand in the craft cannabis segment.
“This latest milestone marks a new and exciting chapter for Radicle and strengthens our confidence in their commitment to deliver premium, small-batch, handcrafted cannabis,” Daniel Pearlstein, EVP strategy for Canopy Rivers, said in a statement.
